Home Machinery & Equipment Industrial Equipment Antibiotic Resistance Market

Antibiotic Resistance Market Size, Share & Trends Analysis Report By Disease (cUTI (Complicated Urinary Tract Infections), CDI (Clostridioides difficile Infection), ABSSSI (Acute bacterial skin and skin structure infections), HABP (Hospital-acquired bacterial pneumonia), CABP (Community-acquired pneumonia), cIAI (Complicated intra-abdominal infection), BSI (Bloodstream infection)), By Pathogen (coli, pneumoniae, aeruginosa, aureus, baumannii, influenzae, difficile, faecium), By Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, Combination therapies, Cephalosporins, Others), By Mechanism of Action (Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors, RNA Synthesis Inhibitors, DNA Synthesis Inhibitors, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: December 17, 2025 | Author: Debashree B | Format: | Report Code: SR7596DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Antibiotic Resistance Market Size Analysis
    1. Introduction
    2. Antibiotic Resistance Market Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
      1. cUTI (Complicated Urinary Tract Infections)
      2. CDI (Clostridioides difficile Infection)
      3. ABSSSI (Acute bacterial skin and skin structure infections)
      4. HABP (Hospital-acquired bacterial pneumonia)
      5. CABP (Community-acquired pneumonia)
      6. cIAI (Complicated intra-abdominal infection)
      7. BSI (Bloodstream infection)
    3. Antibiotic Resistance Market Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
      1. coli
      2. pneumoniae
      3. aeruginosa
      4. aureus
      5. baumannii
      6. influenzae
      7. difficile
      8. faecium
    4. Antibiotic Resistance Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Oxazolidinones
      2. Lipoglycopeptides
      3. Tetracyclines
      4. Combination therapies
      5. Cephalosporins
      6. Others
    5. Antibiotic Resistance Market Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
      1. Protein Synthesis Inhibitors
      2. Cell Wall Synthesis Inhibitors
      3. RNA Synthesis Inhibitors
      4. DNA Synthesis Inhibitors
      5. Others
    6. Antibiotic Resistance Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
  7. North America Antibiotic Resistance Market Size Analysis
    1. Introduction
    2. Antibiotic Resistance Market Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
      1. cUTI (Complicated Urinary Tract Infections)
      2. CDI (Clostridioides difficile Infection)
      3. ABSSSI (Acute bacterial skin and skin structure infections)
      4. HABP (Hospital-acquired bacterial pneumonia)
      5. CABP (Community-acquired pneumonia)
      6. cIAI (Complicated intra-abdominal infection)
      7. BSI (Bloodstream infection)
    3. Antibiotic Resistance Market Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
      1. coli
      2. pneumoniae
      3. aeruginosa
      4. aureus
      5. baumannii
      6. influenzae
      7. difficile
      8. faecium
    4. Antibiotic Resistance Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Oxazolidinones
      2. Lipoglycopeptides
      3. Tetracyclines
      4. Combination therapies
      5. Cephalosporins
      6. Others
    5. Antibiotic Resistance Market Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
      1. Protein Synthesis Inhibitors
      2. Cell Wall Synthesis Inhibitors
      3. RNA Synthesis Inhibitors
      4. DNA Synthesis Inhibitors
      5. Others
    6. Antibiotic Resistance Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    7. U.S.
      1. Introduction
      2. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. cUTI (Complicated Urinary Tract Infections)
        2. CDI (Clostridioides difficile Infection)
        3. ABSSSI (Acute bacterial skin and skin structure infections)
        4. HABP (Hospital-acquired bacterial pneumonia)
        5. CABP (Community-acquired pneumonia)
        6. cIAI (Complicated intra-abdominal infection)
        7. BSI (Bloodstream infection)
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. coli
        2. pneumoniae
        3. aeruginosa
        4. aureus
        5. baumannii
        6. influenzae
        7. difficile
        8. faecium
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Oxazolidinones
        2. Lipoglycopeptides
        3. Tetracyclines
        4. Combination therapies
        5. Cephalosporins
        6. Others
      5. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Protein Synthesis Inhibitors
        2. Cell Wall Synthesis Inhibitors
        3. RNA Synthesis Inhibitors
        4. DNA Synthesis Inhibitors
        5. Others
      6. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    8. Canada
      1. Introduction
      2. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. cUTI (Complicated Urinary Tract Infections)
        2. CDI (Clostridioides difficile Infection)
        3. ABSSSI (Acute bacterial skin and skin structure infections)
        4. HABP (Hospital-acquired bacterial pneumonia)
        5. CABP (Community-acquired pneumonia)
        6. cIAI (Complicated intra-abdominal infection)
        7. BSI (Bloodstream infection)
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. coli
        2. pneumoniae
        3. aeruginosa
        4. aureus
        5. baumannii
        6. influenzae
        7. difficile
        8. faecium
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Oxazolidinones
        2. Lipoglycopeptides
        3. Tetracyclines
        4. Combination therapies
        5. Cephalosporins
        6. Others
      5. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Protein Synthesis Inhibitors
        2. Cell Wall Synthesis Inhibitors
        3. RNA Synthesis Inhibitors
        4. DNA Synthesis Inhibitors
        5. Others
      6. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
  8. Europe Antibiotic Resistance Market Size Analysis
    1. Introduction
    2. Antibiotic Resistance Market Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
      1. cUTI (Complicated Urinary Tract Infections)
      2. CDI (Clostridioides difficile Infection)
      3. ABSSSI (Acute bacterial skin and skin structure infections)
      4. HABP (Hospital-acquired bacterial pneumonia)
      5. CABP (Community-acquired pneumonia)
      6. cIAI (Complicated intra-abdominal infection)
      7. BSI (Bloodstream infection)
    3. Antibiotic Resistance Market Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
      1. coli
      2. pneumoniae
      3. aeruginosa
      4. aureus
      5. baumannii
      6. influenzae
      7. difficile
      8. faecium
    4. Antibiotic Resistance Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Oxazolidinones
      2. Lipoglycopeptides
      3. Tetracyclines
      4. Combination therapies
      5. Cephalosporins
      6. Others
    5. Antibiotic Resistance Market Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
      1. Protein Synthesis Inhibitors
      2. Cell Wall Synthesis Inhibitors
      3. RNA Synthesis Inhibitors
      4. DNA Synthesis Inhibitors
      5. Others
    6. Antibiotic Resistance Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    7. U.K.
      1. Introduction
      2. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. cUTI (Complicated Urinary Tract Infections)
        2. CDI (Clostridioides difficile Infection)
        3. ABSSSI (Acute bacterial skin and skin structure infections)
        4. HABP (Hospital-acquired bacterial pneumonia)
        5. CABP (Community-acquired pneumonia)
        6. cIAI (Complicated intra-abdominal infection)
        7. BSI (Bloodstream infection)
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. coli
        2. pneumoniae
        3. aeruginosa
        4. aureus
        5. baumannii
        6. influenzae
        7. difficile
        8. faecium
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Oxazolidinones
        2. Lipoglycopeptides
        3. Tetracyclines
        4. Combination therapies
        5. Cephalosporins
        6. Others
      5. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Protein Synthesis Inhibitors
        2. Cell Wall Synthesis Inhibitors
        3. RNA Synthesis Inhibitors
        4. DNA Synthesis Inhibitors
        5. Others
      6. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    8. Germany
      1. Introduction
      2. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. cUTI (Complicated Urinary Tract Infections)
        2. CDI (Clostridioides difficile Infection)
        3. ABSSSI (Acute bacterial skin and skin structure infections)
        4. HABP (Hospital-acquired bacterial pneumonia)
        5. CABP (Community-acquired pneumonia)
        6. cIAI (Complicated intra-abdominal infection)
        7. BSI (Bloodstream infection)
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. coli
        2. pneumoniae
        3. aeruginosa
        4. aureus
        5. baumannii
        6. influenzae
        7. difficile
        8. faecium
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Oxazolidinones
        2. Lipoglycopeptides
        3. Tetracyclines
        4. Combination therapies
        5. Cephalosporins
        6. Others
      5. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Protein Synthesis Inhibitors
        2. Cell Wall Synthesis Inhibitors
        3. RNA Synthesis Inhibitors
        4. DNA Synthesis Inhibitors
        5. Others
      6. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    9. France
      1. Introduction
      2. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. cUTI (Complicated Urinary Tract Infections)
        2. CDI (Clostridioides difficile Infection)
        3. ABSSSI (Acute bacterial skin and skin structure infections)
        4. HABP (Hospital-acquired bacterial pneumonia)
        5. CABP (Community-acquired pneumonia)
        6. cIAI (Complicated intra-abdominal infection)
        7. BSI (Bloodstream infection)
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. coli
        2. pneumoniae
        3. aeruginosa
        4. aureus
        5. baumannii
        6. influenzae
        7. difficile
        8. faecium
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Oxazolidinones
        2. Lipoglycopeptides
        3. Tetracyclines
        4. Combination therapies
        5. Cephalosporins
        6. Others
      5. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Protein Synthesis Inhibitors
        2. Cell Wall Synthesis Inhibitors
        3. RNA Synthesis Inhibitors
        4. DNA Synthesis Inhibitors
        5. Others
      6. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    10. Spain
      1. Introduction
      2. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. cUTI (Complicated Urinary Tract Infections)
        2. CDI (Clostridioides difficile Infection)
        3. ABSSSI (Acute bacterial skin and skin structure infections)
        4. HABP (Hospital-acquired bacterial pneumonia)
        5. CABP (Community-acquired pneumonia)
        6. cIAI (Complicated intra-abdominal infection)
        7. BSI (Bloodstream infection)
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. coli
        2. pneumoniae
        3. aeruginosa
        4. aureus
        5. baumannii
        6. influenzae
        7. difficile
        8. faecium
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Oxazolidinones
        2. Lipoglycopeptides
        3. Tetracyclines
        4. Combination therapies
        5. Cephalosporins
        6. Others
      5. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Protein Synthesis Inhibitors
        2. Cell Wall Synthesis Inhibitors
        3. RNA Synthesis Inhibitors
        4. DNA Synthesis Inhibitors
        5. Others
      6. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    11. Italy
      1. Introduction
      2. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. cUTI (Complicated Urinary Tract Infections)
        2. CDI (Clostridioides difficile Infection)
        3. ABSSSI (Acute bacterial skin and skin structure infections)
        4. HABP (Hospital-acquired bacterial pneumonia)
        5. CABP (Community-acquired pneumonia)
        6. cIAI (Complicated intra-abdominal infection)
        7. BSI (Bloodstream infection)
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. coli
        2. pneumoniae
        3. aeruginosa
        4. aureus
        5. baumannii
        6. influenzae
        7. difficile
        8. faecium
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Oxazolidinones
        2. Lipoglycopeptides
        3. Tetracyclines
        4. Combination therapies
        5. Cephalosporins
        6. Others
      5. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Protein Synthesis Inhibitors
        2. Cell Wall Synthesis Inhibitors
        3. RNA Synthesis Inhibitors
        4. DNA Synthesis Inhibitors
        5. Others
      6. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    12. Russia
      1. Introduction
      2. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. cUTI (Complicated Urinary Tract Infections)
        2. CDI (Clostridioides difficile Infection)
        3. ABSSSI (Acute bacterial skin and skin structure infections)
        4. HABP (Hospital-acquired bacterial pneumonia)
        5. CABP (Community-acquired pneumonia)
        6. cIAI (Complicated intra-abdominal infection)
        7. BSI (Bloodstream infection)
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. coli
        2. pneumoniae
        3. aeruginosa
        4. aureus
        5. baumannii
        6. influenzae
        7. difficile
        8. faecium
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Oxazolidinones
        2. Lipoglycopeptides
        3. Tetracyclines
        4. Combination therapies
        5. Cephalosporins
        6. Others
      5. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Protein Synthesis Inhibitors
        2. Cell Wall Synthesis Inhibitors
        3. RNA Synthesis Inhibitors
        4. DNA Synthesis Inhibitors
        5. Others
      6. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    13. Nordic
      1. Introduction
      2. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. cUTI (Complicated Urinary Tract Infections)
        2. CDI (Clostridioides difficile Infection)
        3. ABSSSI (Acute bacterial skin and skin structure infections)
        4. HABP (Hospital-acquired bacterial pneumonia)
        5. CABP (Community-acquired pneumonia)
        6. cIAI (Complicated intra-abdominal infection)
        7. BSI (Bloodstream infection)
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. coli
        2. pneumoniae
        3. aeruginosa
        4. aureus
        5. baumannii
        6. influenzae
        7. difficile
        8. faecium
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Oxazolidinones
        2. Lipoglycopeptides
        3. Tetracyclines
        4. Combination therapies
        5. Cephalosporins
        6. Others
      5. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Protein Synthesis Inhibitors
        2. Cell Wall Synthesis Inhibitors
        3. RNA Synthesis Inhibitors
        4. DNA Synthesis Inhibitors
        5. Others
      6. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    14. Benelux
      1. Introduction
      2. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. cUTI (Complicated Urinary Tract Infections)
        2. CDI (Clostridioides difficile Infection)
        3. ABSSSI (Acute bacterial skin and skin structure infections)
        4. HABP (Hospital-acquired bacterial pneumonia)
        5. CABP (Community-acquired pneumonia)
        6. cIAI (Complicated intra-abdominal infection)
        7. BSI (Bloodstream infection)
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. coli
        2. pneumoniae
        3. aeruginosa
        4. aureus
        5. baumannii
        6. influenzae
        7. difficile
        8. faecium
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Oxazolidinones
        2. Lipoglycopeptides
        3. Tetracyclines
        4. Combination therapies
        5. Cephalosporins
        6. Others
      5. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Protein Synthesis Inhibitors
        2. Cell Wall Synthesis Inhibitors
        3. RNA Synthesis Inhibitors
        4. DNA Synthesis Inhibitors
        5. Others
      6. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    15. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. cUTI (Complicated Urinary Tract Infections)
        2. CDI (Clostridioides difficile Infection)
        3. ABSSSI (Acute bacterial skin and skin structure infections)
        4. HABP (Hospital-acquired bacterial pneumonia)
        5. CABP (Community-acquired pneumonia)
        6. cIAI (Complicated intra-abdominal infection)
        7. BSI (Bloodstream infection)
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. coli
        2. pneumoniae
        3. aeruginosa
        4. aureus
        5. baumannii
        6. influenzae
        7. difficile
        8. faecium
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Oxazolidinones
        2. Lipoglycopeptides
        3. Tetracyclines
        4. Combination therapies
        5. Cephalosporins
        6. Others
      5. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Protein Synthesis Inhibitors
        2. Cell Wall Synthesis Inhibitors
        3. RNA Synthesis Inhibitors
        4. DNA Synthesis Inhibitors
        5. Others
      6. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
  9. APAC Antibiotic Resistance Market Size Analysis
    1. Introduction
    2. Antibiotic Resistance Market Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
      1. cUTI (Complicated Urinary Tract Infections)
      2. CDI (Clostridioides difficile Infection)
      3. ABSSSI (Acute bacterial skin and skin structure infections)
      4. HABP (Hospital-acquired bacterial pneumonia)
      5. CABP (Community-acquired pneumonia)
      6. cIAI (Complicated intra-abdominal infection)
      7. BSI (Bloodstream infection)
    3. Antibiotic Resistance Market Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
      1. coli
      2. pneumoniae
      3. aeruginosa
      4. aureus
      5. baumannii
      6. influenzae
      7. difficile
      8. faecium
    4. Antibiotic Resistance Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Oxazolidinones
      2. Lipoglycopeptides
      3. Tetracyclines
      4. Combination therapies
      5. Cephalosporins
      6. Others
    5. Antibiotic Resistance Market Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
      1. Protein Synthesis Inhibitors
      2. Cell Wall Synthesis Inhibitors
      3. RNA Synthesis Inhibitors
      4. DNA Synthesis Inhibitors
      5. Others
    6. Antibiotic Resistance Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    7. China
      1. Introduction
      2. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. cUTI (Complicated Urinary Tract Infections)
        2. CDI (Clostridioides difficile Infection)
        3. ABSSSI (Acute bacterial skin and skin structure infections)
        4. HABP (Hospital-acquired bacterial pneumonia)
        5. CABP (Community-acquired pneumonia)
        6. cIAI (Complicated intra-abdominal infection)
        7. BSI (Bloodstream infection)
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. coli
        2. pneumoniae
        3. aeruginosa
        4. aureus
        5. baumannii
        6. influenzae
        7. difficile
        8. faecium
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Oxazolidinones
        2. Lipoglycopeptides
        3. Tetracyclines
        4. Combination therapies
        5. Cephalosporins
        6. Others
      5. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Protein Synthesis Inhibitors
        2. Cell Wall Synthesis Inhibitors
        3. RNA Synthesis Inhibitors
        4. DNA Synthesis Inhibitors
        5. Others
      6. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    8. Korea
      1. Introduction
      2. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. cUTI (Complicated Urinary Tract Infections)
        2. CDI (Clostridioides difficile Infection)
        3. ABSSSI (Acute bacterial skin and skin structure infections)
        4. HABP (Hospital-acquired bacterial pneumonia)
        5. CABP (Community-acquired pneumonia)
        6. cIAI (Complicated intra-abdominal infection)
        7. BSI (Bloodstream infection)
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. coli
        2. pneumoniae
        3. aeruginosa
        4. aureus
        5. baumannii
        6. influenzae
        7. difficile
        8. faecium
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Oxazolidinones
        2. Lipoglycopeptides
        3. Tetracyclines
        4. Combination therapies
        5. Cephalosporins
        6. Others
      5. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Protein Synthesis Inhibitors
        2. Cell Wall Synthesis Inhibitors
        3. RNA Synthesis Inhibitors
        4. DNA Synthesis Inhibitors
        5. Others
      6. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    9. Japan
      1. Introduction
      2. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. cUTI (Complicated Urinary Tract Infections)
        2. CDI (Clostridioides difficile Infection)
        3. ABSSSI (Acute bacterial skin and skin structure infections)
        4. HABP (Hospital-acquired bacterial pneumonia)
        5. CABP (Community-acquired pneumonia)
        6. cIAI (Complicated intra-abdominal infection)
        7. BSI (Bloodstream infection)
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. coli
        2. pneumoniae
        3. aeruginosa
        4. aureus
        5. baumannii
        6. influenzae
        7. difficile
        8. faecium
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Oxazolidinones
        2. Lipoglycopeptides
        3. Tetracyclines
        4. Combination therapies
        5. Cephalosporins
        6. Others
      5. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Protein Synthesis Inhibitors
        2. Cell Wall Synthesis Inhibitors
        3. RNA Synthesis Inhibitors
        4. DNA Synthesis Inhibitors
        5. Others
      6. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    10. India
      1. Introduction
      2. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. cUTI (Complicated Urinary Tract Infections)
        2. CDI (Clostridioides difficile Infection)
        3. ABSSSI (Acute bacterial skin and skin structure infections)
        4. HABP (Hospital-acquired bacterial pneumonia)
        5. CABP (Community-acquired pneumonia)
        6. cIAI (Complicated intra-abdominal infection)
        7. BSI (Bloodstream infection)
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. coli
        2. pneumoniae
        3. aeruginosa
        4. aureus
        5. baumannii
        6. influenzae
        7. difficile
        8. faecium
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Oxazolidinones
        2. Lipoglycopeptides
        3. Tetracyclines
        4. Combination therapies
        5. Cephalosporins
        6. Others
      5. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Protein Synthesis Inhibitors
        2. Cell Wall Synthesis Inhibitors
        3. RNA Synthesis Inhibitors
        4. DNA Synthesis Inhibitors
        5. Others
      6. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    11. Australia
      1. Introduction
      2. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. cUTI (Complicated Urinary Tract Infections)
        2. CDI (Clostridioides difficile Infection)
        3. ABSSSI (Acute bacterial skin and skin structure infections)
        4. HABP (Hospital-acquired bacterial pneumonia)
        5. CABP (Community-acquired pneumonia)
        6. cIAI (Complicated intra-abdominal infection)
        7. BSI (Bloodstream infection)
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. coli
        2. pneumoniae
        3. aeruginosa
        4. aureus
        5. baumannii
        6. influenzae
        7. difficile
        8. faecium
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Oxazolidinones
        2. Lipoglycopeptides
        3. Tetracyclines
        4. Combination therapies
        5. Cephalosporins
        6. Others
      5. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Protein Synthesis Inhibitors
        2. Cell Wall Synthesis Inhibitors
        3. RNA Synthesis Inhibitors
        4. DNA Synthesis Inhibitors
        5. Others
      6. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    12. Taiwan
      1. Introduction
      2. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. cUTI (Complicated Urinary Tract Infections)
        2. CDI (Clostridioides difficile Infection)
        3. ABSSSI (Acute bacterial skin and skin structure infections)
        4. HABP (Hospital-acquired bacterial pneumonia)
        5. CABP (Community-acquired pneumonia)
        6. cIAI (Complicated intra-abdominal infection)
        7. BSI (Bloodstream infection)
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. coli
        2. pneumoniae
        3. aeruginosa
        4. aureus
        5. baumannii
        6. influenzae
        7. difficile
        8. faecium
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Oxazolidinones
        2. Lipoglycopeptides
        3. Tetracyclines
        4. Combination therapies
        5. Cephalosporins
        6. Others
      5. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Protein Synthesis Inhibitors
        2. Cell Wall Synthesis Inhibitors
        3. RNA Synthesis Inhibitors
        4. DNA Synthesis Inhibitors
        5. Others
      6. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    13. South East Asia
      1. Introduction
      2. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. cUTI (Complicated Urinary Tract Infections)
        2. CDI (Clostridioides difficile Infection)
        3. ABSSSI (Acute bacterial skin and skin structure infections)
        4. HABP (Hospital-acquired bacterial pneumonia)
        5. CABP (Community-acquired pneumonia)
        6. cIAI (Complicated intra-abdominal infection)
        7. BSI (Bloodstream infection)
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. coli
        2. pneumoniae
        3. aeruginosa
        4. aureus
        5. baumannii
        6. influenzae
        7. difficile
        8. faecium
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Oxazolidinones
        2. Lipoglycopeptides
        3. Tetracyclines
        4. Combination therapies
        5. Cephalosporins
        6. Others
      5. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Protein Synthesis Inhibitors
        2. Cell Wall Synthesis Inhibitors
        3. RNA Synthesis Inhibitors
        4. DNA Synthesis Inhibitors
        5. Others
      6. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    14. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. cUTI (Complicated Urinary Tract Infections)
        2. CDI (Clostridioides difficile Infection)
        3. ABSSSI (Acute bacterial skin and skin structure infections)
        4. HABP (Hospital-acquired bacterial pneumonia)
        5. CABP (Community-acquired pneumonia)
        6. cIAI (Complicated intra-abdominal infection)
        7. BSI (Bloodstream infection)
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. coli
        2. pneumoniae
        3. aeruginosa
        4. aureus
        5. baumannii
        6. influenzae
        7. difficile
        8. faecium
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Oxazolidinones
        2. Lipoglycopeptides
        3. Tetracyclines
        4. Combination therapies
        5. Cephalosporins
        6. Others
      5. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Protein Synthesis Inhibitors
        2. Cell Wall Synthesis Inhibitors
        3. RNA Synthesis Inhibitors
        4. DNA Synthesis Inhibitors
        5. Others
      6. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
  10. Middle East and Africa Antibiotic Resistance Market Size Analysis
    1. Introduction
    2. Antibiotic Resistance Market Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
      1. cUTI (Complicated Urinary Tract Infections)
      2. CDI (Clostridioides difficile Infection)
      3. ABSSSI (Acute bacterial skin and skin structure infections)
      4. HABP (Hospital-acquired bacterial pneumonia)
      5. CABP (Community-acquired pneumonia)
      6. cIAI (Complicated intra-abdominal infection)
      7. BSI (Bloodstream infection)
    3. Antibiotic Resistance Market Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
      1. coli
      2. pneumoniae
      3. aeruginosa
      4. aureus
      5. baumannii
      6. influenzae
      7. difficile
      8. faecium
    4. Antibiotic Resistance Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Oxazolidinones
      2. Lipoglycopeptides
      3. Tetracyclines
      4. Combination therapies
      5. Cephalosporins
      6. Others
    5. Antibiotic Resistance Market Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
      1. Protein Synthesis Inhibitors
      2. Cell Wall Synthesis Inhibitors
      3. RNA Synthesis Inhibitors
      4. DNA Synthesis Inhibitors
      5. Others
    6. Antibiotic Resistance Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    7. UAE
      1. Introduction
      2. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. cUTI (Complicated Urinary Tract Infections)
        2. CDI (Clostridioides difficile Infection)
        3. ABSSSI (Acute bacterial skin and skin structure infections)
        4. HABP (Hospital-acquired bacterial pneumonia)
        5. CABP (Community-acquired pneumonia)
        6. cIAI (Complicated intra-abdominal infection)
        7. BSI (Bloodstream infection)
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. coli
        2. pneumoniae
        3. aeruginosa
        4. aureus
        5. baumannii
        6. influenzae
        7. difficile
        8. faecium
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Oxazolidinones
        2. Lipoglycopeptides
        3. Tetracyclines
        4. Combination therapies
        5. Cephalosporins
        6. Others
      5. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Protein Synthesis Inhibitors
        2. Cell Wall Synthesis Inhibitors
        3. RNA Synthesis Inhibitors
        4. DNA Synthesis Inhibitors
        5. Others
      6. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    8. Turkey
      1. Introduction
      2. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. cUTI (Complicated Urinary Tract Infections)
        2. CDI (Clostridioides difficile Infection)
        3. ABSSSI (Acute bacterial skin and skin structure infections)
        4. HABP (Hospital-acquired bacterial pneumonia)
        5. CABP (Community-acquired pneumonia)
        6. cIAI (Complicated intra-abdominal infection)
        7. BSI (Bloodstream infection)
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. coli
        2. pneumoniae
        3. aeruginosa
        4. aureus
        5. baumannii
        6. influenzae
        7. difficile
        8. faecium
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Oxazolidinones
        2. Lipoglycopeptides
        3. Tetracyclines
        4. Combination therapies
        5. Cephalosporins
        6. Others
      5. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Protein Synthesis Inhibitors
        2. Cell Wall Synthesis Inhibitors
        3. RNA Synthesis Inhibitors
        4. DNA Synthesis Inhibitors
        5. Others
      6. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    9. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. cUTI (Complicated Urinary Tract Infections)
        2. CDI (Clostridioides difficile Infection)
        3. ABSSSI (Acute bacterial skin and skin structure infections)
        4. HABP (Hospital-acquired bacterial pneumonia)
        5. CABP (Community-acquired pneumonia)
        6. cIAI (Complicated intra-abdominal infection)
        7. BSI (Bloodstream infection)
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. coli
        2. pneumoniae
        3. aeruginosa
        4. aureus
        5. baumannii
        6. influenzae
        7. difficile
        8. faecium
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Oxazolidinones
        2. Lipoglycopeptides
        3. Tetracyclines
        4. Combination therapies
        5. Cephalosporins
        6. Others
      5. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Protein Synthesis Inhibitors
        2. Cell Wall Synthesis Inhibitors
        3. RNA Synthesis Inhibitors
        4. DNA Synthesis Inhibitors
        5. Others
      6. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    10. South Africa
      1. Introduction
      2. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. cUTI (Complicated Urinary Tract Infections)
        2. CDI (Clostridioides difficile Infection)
        3. ABSSSI (Acute bacterial skin and skin structure infections)
        4. HABP (Hospital-acquired bacterial pneumonia)
        5. CABP (Community-acquired pneumonia)
        6. cIAI (Complicated intra-abdominal infection)
        7. BSI (Bloodstream infection)
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. coli
        2. pneumoniae
        3. aeruginosa
        4. aureus
        5. baumannii
        6. influenzae
        7. difficile
        8. faecium
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Oxazolidinones
        2. Lipoglycopeptides
        3. Tetracyclines
        4. Combination therapies
        5. Cephalosporins
        6. Others
      5. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Protein Synthesis Inhibitors
        2. Cell Wall Synthesis Inhibitors
        3. RNA Synthesis Inhibitors
        4. DNA Synthesis Inhibitors
        5. Others
      6. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    11. Egypt
      1. Introduction
      2. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. cUTI (Complicated Urinary Tract Infections)
        2. CDI (Clostridioides difficile Infection)
        3. ABSSSI (Acute bacterial skin and skin structure infections)
        4. HABP (Hospital-acquired bacterial pneumonia)
        5. CABP (Community-acquired pneumonia)
        6. cIAI (Complicated intra-abdominal infection)
        7. BSI (Bloodstream infection)
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. coli
        2. pneumoniae
        3. aeruginosa
        4. aureus
        5. baumannii
        6. influenzae
        7. difficile
        8. faecium
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Oxazolidinones
        2. Lipoglycopeptides
        3. Tetracyclines
        4. Combination therapies
        5. Cephalosporins
        6. Others
      5. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Protein Synthesis Inhibitors
        2. Cell Wall Synthesis Inhibitors
        3. RNA Synthesis Inhibitors
        4. DNA Synthesis Inhibitors
        5. Others
      6. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    12. Nigeria
      1. Introduction
      2. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. cUTI (Complicated Urinary Tract Infections)
        2. CDI (Clostridioides difficile Infection)
        3. ABSSSI (Acute bacterial skin and skin structure infections)
        4. HABP (Hospital-acquired bacterial pneumonia)
        5. CABP (Community-acquired pneumonia)
        6. cIAI (Complicated intra-abdominal infection)
        7. BSI (Bloodstream infection)
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. coli
        2. pneumoniae
        3. aeruginosa
        4. aureus
        5. baumannii
        6. influenzae
        7. difficile
        8. faecium
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Oxazolidinones
        2. Lipoglycopeptides
        3. Tetracyclines
        4. Combination therapies
        5. Cephalosporins
        6. Others
      5. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Protein Synthesis Inhibitors
        2. Cell Wall Synthesis Inhibitors
        3. RNA Synthesis Inhibitors
        4. DNA Synthesis Inhibitors
        5. Others
      6. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    13. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. cUTI (Complicated Urinary Tract Infections)
        2. CDI (Clostridioides difficile Infection)
        3. ABSSSI (Acute bacterial skin and skin structure infections)
        4. HABP (Hospital-acquired bacterial pneumonia)
        5. CABP (Community-acquired pneumonia)
        6. cIAI (Complicated intra-abdominal infection)
        7. BSI (Bloodstream infection)
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. coli
        2. pneumoniae
        3. aeruginosa
        4. aureus
        5. baumannii
        6. influenzae
        7. difficile
        8. faecium
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Oxazolidinones
        2. Lipoglycopeptides
        3. Tetracyclines
        4. Combination therapies
        5. Cephalosporins
        6. Others
      5. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Protein Synthesis Inhibitors
        2. Cell Wall Synthesis Inhibitors
        3. RNA Synthesis Inhibitors
        4. DNA Synthesis Inhibitors
        5. Others
      6. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
  11. LATAM Antibiotic Resistance Market Size Analysis
    1. Introduction
    2. Antibiotic Resistance Market Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
      1. cUTI (Complicated Urinary Tract Infections)
      2. CDI (Clostridioides difficile Infection)
      3. ABSSSI (Acute bacterial skin and skin structure infections)
      4. HABP (Hospital-acquired bacterial pneumonia)
      5. CABP (Community-acquired pneumonia)
      6. cIAI (Complicated intra-abdominal infection)
      7. BSI (Bloodstream infection)
    3. Antibiotic Resistance Market Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
      1. coli
      2. pneumoniae
      3. aeruginosa
      4. aureus
      5. baumannii
      6. influenzae
      7. difficile
      8. faecium
    4. Antibiotic Resistance Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Oxazolidinones
      2. Lipoglycopeptides
      3. Tetracyclines
      4. Combination therapies
      5. Cephalosporins
      6. Others
    5. Antibiotic Resistance Market Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
      1. Protein Synthesis Inhibitors
      2. Cell Wall Synthesis Inhibitors
      3. RNA Synthesis Inhibitors
      4. DNA Synthesis Inhibitors
      5. Others
    6. Antibiotic Resistance Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    7. Brazil
      1. Introduction
      2. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. cUTI (Complicated Urinary Tract Infections)
        2. CDI (Clostridioides difficile Infection)
        3. ABSSSI (Acute bacterial skin and skin structure infections)
        4. HABP (Hospital-acquired bacterial pneumonia)
        5. CABP (Community-acquired pneumonia)
        6. cIAI (Complicated intra-abdominal infection)
        7. BSI (Bloodstream infection)
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. coli
        2. pneumoniae
        3. aeruginosa
        4. aureus
        5. baumannii
        6. influenzae
        7. difficile
        8. faecium
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Oxazolidinones
        2. Lipoglycopeptides
        3. Tetracyclines
        4. Combination therapies
        5. Cephalosporins
        6. Others
      5. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Protein Synthesis Inhibitors
        2. Cell Wall Synthesis Inhibitors
        3. RNA Synthesis Inhibitors
        4. DNA Synthesis Inhibitors
        5. Others
      6. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    8. Mexico
      1. Introduction
      2. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. cUTI (Complicated Urinary Tract Infections)
        2. CDI (Clostridioides difficile Infection)
        3. ABSSSI (Acute bacterial skin and skin structure infections)
        4. HABP (Hospital-acquired bacterial pneumonia)
        5. CABP (Community-acquired pneumonia)
        6. cIAI (Complicated intra-abdominal infection)
        7. BSI (Bloodstream infection)
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. coli
        2. pneumoniae
        3. aeruginosa
        4. aureus
        5. baumannii
        6. influenzae
        7. difficile
        8. faecium
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Oxazolidinones
        2. Lipoglycopeptides
        3. Tetracyclines
        4. Combination therapies
        5. Cephalosporins
        6. Others
      5. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Protein Synthesis Inhibitors
        2. Cell Wall Synthesis Inhibitors
        3. RNA Synthesis Inhibitors
        4. DNA Synthesis Inhibitors
        5. Others
      6. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    9. Argentina
      1. Introduction
      2. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. cUTI (Complicated Urinary Tract Infections)
        2. CDI (Clostridioides difficile Infection)
        3. ABSSSI (Acute bacterial skin and skin structure infections)
        4. HABP (Hospital-acquired bacterial pneumonia)
        5. CABP (Community-acquired pneumonia)
        6. cIAI (Complicated intra-abdominal infection)
        7. BSI (Bloodstream infection)
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. coli
        2. pneumoniae
        3. aeruginosa
        4. aureus
        5. baumannii
        6. influenzae
        7. difficile
        8. faecium
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Oxazolidinones
        2. Lipoglycopeptides
        3. Tetracyclines
        4. Combination therapies
        5. Cephalosporins
        6. Others
      5. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Protein Synthesis Inhibitors
        2. Cell Wall Synthesis Inhibitors
        3. RNA Synthesis Inhibitors
        4. DNA Synthesis Inhibitors
        5. Others
      6. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    10. Chile
      1. Introduction
      2. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. cUTI (Complicated Urinary Tract Infections)
        2. CDI (Clostridioides difficile Infection)
        3. ABSSSI (Acute bacterial skin and skin structure infections)
        4. HABP (Hospital-acquired bacterial pneumonia)
        5. CABP (Community-acquired pneumonia)
        6. cIAI (Complicated intra-abdominal infection)
        7. BSI (Bloodstream infection)
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. coli
        2. pneumoniae
        3. aeruginosa
        4. aureus
        5. baumannii
        6. influenzae
        7. difficile
        8. faecium
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Oxazolidinones
        2. Lipoglycopeptides
        3. Tetracyclines
        4. Combination therapies
        5. Cephalosporins
        6. Others
      5. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Protein Synthesis Inhibitors
        2. Cell Wall Synthesis Inhibitors
        3. RNA Synthesis Inhibitors
        4. DNA Synthesis Inhibitors
        5. Others
      6. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    11. Colombia
      1. Introduction
      2. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. cUTI (Complicated Urinary Tract Infections)
        2. CDI (Clostridioides difficile Infection)
        3. ABSSSI (Acute bacterial skin and skin structure infections)
        4. HABP (Hospital-acquired bacterial pneumonia)
        5. CABP (Community-acquired pneumonia)
        6. cIAI (Complicated intra-abdominal infection)
        7. BSI (Bloodstream infection)
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. coli
        2. pneumoniae
        3. aeruginosa
        4. aureus
        5. baumannii
        6. influenzae
        7. difficile
        8. faecium
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Oxazolidinones
        2. Lipoglycopeptides
        3. Tetracyclines
        4. Combination therapies
        5. Cephalosporins
        6. Others
      5. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Protein Synthesis Inhibitors
        2. Cell Wall Synthesis Inhibitors
        3. RNA Synthesis Inhibitors
        4. DNA Synthesis Inhibitors
        5. Others
      6. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    12. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. cUTI (Complicated Urinary Tract Infections)
        2. CDI (Clostridioides difficile Infection)
        3. ABSSSI (Acute bacterial skin and skin structure infections)
        4. HABP (Hospital-acquired bacterial pneumonia)
        5. CABP (Community-acquired pneumonia)
        6. cIAI (Complicated intra-abdominal infection)
        7. BSI (Bloodstream infection)
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. coli
        2. pneumoniae
        3. aeruginosa
        4. aureus
        5. baumannii
        6. influenzae
        7. difficile
        8. faecium
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Oxazolidinones
        2. Lipoglycopeptides
        3. Tetracyclines
        4. Combination therapies
        5. Cephalosporins
        6. Others
      5. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Protein Synthesis Inhibitors
        2. Cell Wall Synthesis Inhibitors
        3. RNA Synthesis Inhibitors
        4. DNA Synthesis Inhibitors
        5. Others
      6. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
  12. Competitive Landscape
    1. Antibiotic Resistance Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Sanofi
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Pfizer Inc.
    3. Merck & Co., Inc.
    4. GSK plc.
    5. Abbott
    6. Johnson & Johnson
    7. Novartis AG
    8. Bayer AG
    9. Shionogi & Co., Ltd.
    10. Acurx Pharmaceuticals, Inc.
    11. Melinta Therapeutics LLC
    12. Paratek Pharmaceuticals, Inc.
    13. VenatoRx Pharmaceuticals, Inc.
    14. Spero Therapeutics
    15. Summit Therapeutics Inc.
    16. Theravance Biopharma.
    17. Wockhardt 
    18. Zai Lab
    19. Xellia Pharmaceuticals
    20. Others
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.